Germany’s Ministry for Health, the BMG, wants to switch from Rx to OTC status erectile dysfunction (ED) drugs such as sildenafil and tadalafil.
Speaking at a recent German Medicines Manufacturers’ Association (BAH) annual meeting, the BMG’s Thomas Mueller said that he can imagine switching
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?